Page 1

TM Alector : Next - Generation Medicines for Neurodegeneration October 13 , 2026 Alector's differentiated brain - delivery platform spans antibodies , enzymes , and siRNA , with partnership validation , financial flexibility , and multiple clinical value inflection points through 2028